title: Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research.
abstract: The Eighth Annual Frontiers in Cancer Prevention Research meeting was held in Houston, Texas, in November 2009. This report highlights significant presentations that advance the fields of chemoprevention, clinical trial recruitment and retention, cancer screening including optical imaging, energy balance, and nutritional epidemiology, and health communications and decision making. In findings from the randomized Reduction by Dutasteride of Prostate Cancer Events trial, dutasteride reduced the risk of biopsy-detectable prostate cancer in high-risk men by 23% compared with placebo. Important clues about the dosing and window of susceptibility for supplementation with choline, vitamin D, and folate were revealed from epigenetic research that has implications for future nutritional epidemiology research. Noninvasive optical imaging techniques using endoscopic ultrasound and autofluorescence for the early detection of cancers in the lung, pancreas, and oral cavity are being studied. The report also addresses the challenges of promoting cancer prevention. Understanding how individuals process risk information and make sustained behavior changes and the effect of socioeconomic status on health disparities were identified as critical areas of research. This multidisciplinary research meeting of basic, clinical, and behavioral scientists and epidemiologists continues to play a major role in identifying the research priority areas of cancer prevention, elucidating new mechanisms of carcinogenesis for targeted chemoprevention therapies and delivering a comprehensive strategy for engaging individuals in the unifying goal to reduce cancer incidence.
authors.affiliation: The University of Texas M.D. Anderson Cancer Center, Houston, 77030, USA. abrewster@mdanderson.org
authors.forename: Abenaa M
authors.initials: AM
authors.lastname: Brewster
authors.forename: Sherri L
authors.initials: SL
authors.lastname: Patterson
authors.forename: Michele R
authors.initials: MR
authors.lastname: Forman
authors.forename: Chanita
authors.initials: C
authors.lastname: Hughes-Halbert
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Limburg
authors.forename: Frank G
authors.initials: FG
authors.lastname: Ondrey
authors.forename: Electra D
authors.initials: ED
authors.lastname: Paskett
authors.forename: David W
authors.initials: DW
authors.lastname: Wetter
authors.forename: Ernest T
authors.initials: ET
authors.lastname: Hawk
mesh_terms: D002986:Clinical Trials as Topic / Q000639:trends*; D003226:Congresses as Topic; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D007391:International Cooperation; D008297:Male; D008495:Medical Oncology / Q000379:methods / Q000639:trends*; D009369:Neoplasms / Q000175:diagnosis / Q000517:prevention & control*; D018579:Patient Selection; D012106:Research / Q000639:trends; D012955:Societies, Medical; D014481:United States